Literature DB >> 3055960

Recurrence of IgA nephropathy in renal allografts.

J Berger1.   

Abstract

Mesangial IgA deposits recur in about half of the patients receiving a renal allograft for end-stage renal disease due to IgA nephropathy. However, the course of the recurrent disease is usually mild and rarely causes decreased function of the allograft.

Entities:  

Mesh：

Year:  1988        PMID： 3055960     DOI： 10.1016/s0272-6386(88)80027-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


  22 in total

1.  Oligoclonally expanding gammadelta T lymphocytes induce IgA switching in IgA nephropathy.

Authors:  S Toyabe; W Harada; M Uchiyama
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

Authors:  Hitoshi Suzuki; Run Fan; Zhixin Zhang; Rhubell Brown; Stacy Hall; Bruce A Julian; W Winn Chatham; Yusuke Suzuki; Robert J Wyatt; Zina Moldoveanu; Jeannette Y Lee; James Robinson; Milan Tomana; Yasuhiko Tomino; Jiri Mestecky; Jan Novak
Journal:  J Clin Invest       Date:  2009-05-26       Impact factor: 14.808

Review 3.  Current status of renal transplantation.

Authors:  M G Suranyi; B M Hall
Journal:  West J Med       Date:  1990-06

4.  In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.

Authors:  Takeshi Yanagihara; Rhubell Brown; Stacy Hall; Zina Moldoveanu; Alice Goepfert; Milan Tomana; Bruce A Julian; Jiri Mestecky; Jan Novak
Journal:  Results Immunol       Date:  2012-01-01

5.  Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.

Authors:  Rupali S Avasare; Paul E Rosenstiel; Ziad S Zaky; Demetra S Tsapepas; Gerald B Appel; Glen S Markowitz; Andrew S Bomback; Pietro A Canetta
Journal:  Am J Nephrol       Date:  2017-01-06       Impact factor: 3.754

Review 6.  Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.

Authors:  Taylor Person; R Glenn King; Dana V Rizk; Jan Novak; Todd J Green; Colin Reily
Journal:  J Interferon Cytokine Res       Date:  2022-07-06       Impact factor: 3.657

Review 7.  IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Milan Tomana; Jiri Mestecky
Journal:  Semin Nephrol       Date:  2008-01       Impact factor: 5.299

Review 8.  Pathogenesis of idiopathic IgA nephropathy.

Authors:  D G Williams
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

9.  Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.

Authors:  Maria Messina; Maria Cristina di Vico; Claudia Ariaudo; Gianna Mazzucco; Fabrizio Fop; Giuseppe Paolo Segoloni; Luigi Biancone
Journal:  J Nephrol       Date:  2016-05-23       Impact factor: 3.902

10.  Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.

Authors:  Zina Moldoveanu; Hitoshi Suzuki; Colin Reily; Kenji Satake; Lea Novak; Nuo Xu; Zhi-Qiang Huang; Barbora Knoppova; Atlas Khan; Stacy Hall; Hiroyuki Yanagawa; Rhubell Brown; Colleen J Winstead; Darrell B O'Quinn; Amy Weinmann; Ali G Gharavi; Krzysztof Kiryluk; Bruce A Julian; Casey T Weaver; Yusuke Suzuki; Jan Novak
Journal:  J Autoimmun       Date:  2021-01-25       Impact factor: 7.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.